FRESEN.MED.CARE AG INH ON
FRESEN.MED.CARE AG INH ON/ DE0005785802 /
FME
2024-05-28 9:52:08 AM
|
Chg.
-0.660
|
Volume |
Bid9:58:19 AM |
Ask9:58:19 AM |
Market Capitalization |
Dividend Y. |
P/E Ratio |
38.050EUR
|
-1.70%
|
1,555 Turnover: 59,194.640 |
38.330Bid Size: 521 |
38.380Ask Size: 521 |
11.34 bill.EUR |
3.08% |
22.74 |
Business description
Fresenius Medical Care is the world’s leading provider of products and services for people with chronic kidney failure. Around 2.8 M patients with this disease worldwide regularly undergo dialysis treatment. Dialysis is a vital blood cleansing procedure that substitutes the function of the kidney in case of kidney failure.
Management board & Supervisory board
CEO |
Helen Giza |
Management board |
Martin Fischer, Dr. Katarzyna Mazur-Hofsäß, Frank Maddux, MD, Craig Cordola |
Supervisory board |
Michael Sen, Stefanie Balling, Sara Hennicken, Shervin J. Korangy, Dr. Marcus Kuhnert, Gregory Sorensen, M.D., Pascale Witz, Ralf Erkens, Beate Haßdenteufel, Regina Karsch, Frank Michael Prescher, Dr. Manuela Stauss-Grabo |
Company data
Name: |
Fresenius Medical Care AG & Co. KGaA |
Address: |
Else-Kröner-Straße 1,D-61352 Bad Homburg |
Phone: |
+49-6172-609-0 |
Fax: |
+49-6172-609-2301 |
E-mail: |
-
|
Internet: |
www.fmc-ag.de |
Industry: |
Healthcare |
Sector: |
Medical Products |
Sub sector: |
Advanced Medical Devices |
End of financial year: |
12-31 |
Free Float: |
44.95% |
IPO date: |
1996-10-02 |
Investor relations
Name: |
Dr. Dominic Heger |
IR phone: |
+49 (0) 6172 609-2525 |
IR Fax: |
+49 (0) 6172 609-2301 |
IR e-mail: |
ir@fmc-ag.com
|
Company calendar
CW 31 | 2024-07-30
Interim Report 2nd Quarter/6 Months
|
CW 45 | 2024-11-05
Interim Report 3rd Quarter/9 Months
|